H epatic lipase (HL) and apoE both have critical roles in the metabolism of plasma lipoproteins. 1, 2 Human HL is a 476 -amino-acid glycoprotein that is synthesized by hepatocytes and binds to external surfaces of hepatic cells. 3, 4 Studies in animal models and HL-deficient humans [5] [6] [7] [8] suggested that HL is involved in the conversion of IDLs to LDLs, and in the catabolism of large lipid-rich HDLs (reviewed in Reference 1) . HL also enhances the direct binding and uptake of cholesteryl ester-rich VLDL and chylomicron remnants by hepatocytes. 9 Human apoE is a 299 -amino-acid glycoprotein present mainly in triglyceride-rich particles (chylomicrons, VLDLs, and IDLs) and large HDLs. A major role of apoE in plasma lipid transport is to mediate the binding and clearance of remnant lipoproteins and large cholesterol-rich HDLs to receptors in hepatic and peripheral cells. 2, 10, 11 To determine whether the physiological roles of HL and apoE in plasma cholesterol and lipoprotein metabolism are complementary, we generated transgenic lines of rabbits overexpressing the corresponding human proteins. Rabbits were used because they are naturally deficient in HL and they have relatively reduced levels of apoE compared with other species. 12 , 13 We previously found that overexpression of HL in transgenic rabbits resulted in a reduction in IDLs and all subclasses of HDLs in chow-fed rabbits, as well as a 2-fold reduction in plasma cholesterol, in comparison with nontransgenic controls. 14, 15 Overexpression of apoE in transgenic rabbits was shown to decrease VLDL levels; this effect was due to an increased affinity of large apoE-rich remnants for the LDL receptor that was related to increased chylomicron clearance rate. 16 Although VLDLϩIDL and LDLs are commonly defined as lipoproteins of density Ͻ1.019 and 1.019 to 1.063 g/mL, respectively, among these intervals it is possible to recognize several heterogeneous subclasses, differing in size, density, flotation rate, electrophoretic mobility, and chemical composition. [17] [18] [19] [20] [21] [22] [23] [24] [25] We previously used density-gradient ultracentrifugation (DGUC) and electrophoresis in polyacrylamide gradient gels to demonstrate the existence of multiple distinct subclasses of VLDLs and IDLs in humans. 19, 20 By injecting human lipoproteins into rats, we documented different met-abolic pathways for distinct VLDL and IDL subclasses. 21 The LDLs also contain multiple distinct subpopulations of particles. [22] [23] [24] [25] Studies have demonstrated that individual subclasses may have different metabolic properties, 26 -28 but specific effects of HL and apoE on the metabolism of these subpopulations have not been established. Plasma HDLs are also exceptionally heterogeneous particles and nondenaturing polyacrylamide gradient gel electrophoresis (GGE) can distinguish several subfractions according to size. 29 In the present study, we determined whether the expression of high levels of HL or apoE has specific influences on the levels of individual lipoprotein subfractions in response to dietary cholesterol. We also tested whether the combined expression of HL and apoE has additive effects on plasma lipoprotein levels by cross-breeding rabbits overexpressing either HL or apoE. Our results demonstrate that HL and apoE have complementary and synergistic actions on lipoprotein metabolism and that both components are needed for the maximum protection against hypercholesterolemia in response to dietary cholesterol.
Methods

Protocol
Previously described models of pathogen-free New Zealand White male rabbits transgenic for human HL, 14,15 models transgenic for human apoE, 16 and nontransgenic controls were used in this study. In addition, animals expressing both HL and apoE were produced by cross-breeding of the 2 transgenic strains. Seventeen animals overexpressing human HL, 7 overexpressing human apoE, 4 overexpressing both human HL and apoE, and 15 nontransgenic controls (4 to 6 months of age) were used.
The concentration of human apoE in the rabbits carrying the apoE transgene was 14Ϯ3 mg/dL (meanϮSD), similar to that previously reported 16 and Ϸ5-fold higher than endogenous rabbit apoE. Human HL activity level as measured in postheparin plasma 14, 15 was 54Ϯ6 (meanϮSD) Eq of fatty acid released ⅐ mL Ϫ1 ⅐ h Ϫ1 from a triolein substrate, a level 28-fold higher than the activity found in nontransgenic controls.
All the animals were maintained on a diet containing 17% protein, 12% crude fiber, and 5.5% fat, supplemented with 0.3% cholesterol and 3.0% soybean oil (Zeigler Bros Inc) for 10 weeks. The animals had free access to water and to the diet, and they were housed in a pathogen-free barrier facility with a 12-hour light/dark cycle at 23°C and 55% humidity. All experimental procedures with rabbits were conducted in accordance with NIH guidelines and with the approval of the Committee on Animal Research of the University of California, San Francisco.
Before analysis, rabbits were fasted overnight (14 to 16 hours); then blood was collected (between 8:30 and 9:30 AM) from the intermedial auricular artery and adjusted to a final concentration of 1.5 mg/mL EDTA and 50 U of Trasylol pancreatic protease inhibitor (Miles Laboratory). Plasma was separated by centrifugation at 3000 rpm for 20 minutes at 4°C and analyzed as described below.
Density-Gradient Ultracentrifugation
DGUC of lipoprotein fractions was performed as previously described. 20, 22 In brief, lipoproteins of density (g/mL) Ͻ1.019 (VLDLϩIDL), 1.019 to 1.063 (LDLs), and 1.063 to 1.21 (HDLs) were isolated through preparative ultracentrifugation under standard conditions. 30 Sodium bromide was added to adjust densities and samples were centrifuged at 40 000 rpm for 18 to 20 hours (VLDLϩIDL), 24 to 26 hours (LDLs), and 24 hours (HDLs) at 10°C in a Beckman 40.3 fixed-angle rotor. The VLDLϩIDL fraction was dialyzed against a dϭ1.21 g/mL sodium bromide solution at 4°C with repeated changes over a 24-to 48-hour period. A 4.5-mL sample was placed in a 9 ⁄16ϫ3 1 ⁄2-inch Ultraclear Tube (Beckman Instruments) and sequentially overlayered with 3.0, 3.0, and 1.5 mL, respectively, of sodium bromide solutions of dϭ1.020, 1.010, and 1.000 g/mL. The latter solution consisted of dϭ1.0063 g/mL solution (11.422 g/L NaCl and 0.01% EDTA) diluted 1:5 (vol/vol) with water. The tubes were centrifuged at 17°C in a Beckman SW41 rotor in a Beckman L5-75 ultracentrifuge. The slowest setting for acceleration was used at the start of the run. After 6 hours at 40 000 rpm, the rotor was allowed to coast to a stop without braking. The contents of the tube then were withdrawn by pipetting two 0.5-mL fractions (fractions 1 and 2), three 1.0-mL fractions (fractions 3 to 5), followed by three 0.5-mL fractions (fractions 6 to 8). The bottom 6.5-mL fraction was discarded.
The LDL fraction was dialyzed against a dϭ1.040 g/mL sodium bromide solution at 4°C with repeated changes during a 24-to 48-hour period. An aliquot (2.0 mL) was layered above a solution of dϭ1.054 g/mL (2.5 mL) in a 1 ⁄2ϫ3 1 ⁄2-inch Ultraclear Tube (Beckman Instruments) and 2.5 mL of a solution of dϭ1.0275 g/mL was layered above the lipoprotein fraction. The tubes were centrifuged at 40 000 rpm for 40 hours at 17°C in a Beckman SW45 rotor in a Beckman L5-75 ultracentrifuge under the same conditions as above. The contents of the tube then were withdrawn by pipetting one 0.5-mL fraction (fraction 1), one 1.0-mL fraction (fraction 2), followed by six 0.5-mL fractions (fractions 3 to 8) and two 1.0-mL fractions (fractions 9 and 10). The bottom 0.5-mL fraction was discarded.
Nondenaturing Polyacrylamide GGE
Nondenaturing polyacrylamide GGE of dϽ1.019 and dϭ1.019 to 1.063 g/mL lipoprotein fractions was performed at 10°C in 2% to 14% polyacrylamide gradient gels for 24 hours at 125 V in Tris (0.09 mol/L)/boric acid (0.08 mol/L)/Na 2 EDTA (0.003 mol/L) buffer (pH 8.3) as described elsewhere, 19, 29 except that the gradient gels were prepared in our laboratory essentially as described by Rainwater et al. 31 Gels were fixed and stained for lipids in a solution containing oil red O in 60% ethanol at 55°C or for proteins in a solution containing 0.1% Coomassie Brilliant Blue R-250, 50% ethanol, and 9% acetic acid (vol/vol). Gels were scanned at 530 nm (for oil red O staining) or at 555 nm (for Coomassie Brilliant Blue staining) with a Transidyne densitometer. Migration distance for each absorbance peak was determined, and the molecular diameter corresponding to each peak was calculated from a calibration curve generated from the migration distance of size standards of known diameter, which included carboxylated latex beads (Duke Scientific), thyroglobulin, and apoferritin (HMW Std; Pharmacia) with molecular diameters of 380, 170, and 122 Å, respectively, and lipoprotein calibrators of previously determined particle size.
The HDL fractions were analyzed with GGE as described by Nichols et al, 29 using 3% to 31% gradient gels prepared in our laboratory according to the method of Rainwater et al. 31 Gels were fixed and protein bands stained with Coomassie Brilliant Blue R-250 as described above. Densitometry was used to measure areas in 5 particle size ranges corresponding to human HDL 2b , HDL 2a , HDL 3a , HDL 3b , and HDL 3c . 29 Estimates of the plasma concentrations of these HDL subclasses were obtained by multiplying the percentage of total area for each band by the total plasma HDL protein concentration as described below. Fractions with a diameter of Ͼ120 Å were considered HDL 1 .
Analytical Ultracentrifugation
Analytical ultracentrifugation (AnUC) of VLDLs, IDLs, and LDLs was performed in 3 rabbits overexpressing HL, 3 rabbits overexpressing apoE, 4 rabbits overexpressing both HL and apoE, and 3 nontransgenic controls as previously described. 30 Centrifugation was performed at 26°C and 52 640 rpm at a salt density of 1.063 g/mL in a Spinco Model E instrument equipped with Schlieren optics. Total lipoprotein mass was estimated as a function of Svedberg flotation rate (Sf°), using computer-assisted analytical techniques.
Chemical Composition Determinations
Triglyceride total and unesterified cholesterol levels were measured by using enzymatic methods and a Gilford Impact 400E analyzer (Gilford Instruments). 32, 33 HDL cholesterol was measured after heparin-manganese precipitation of the apoB containing lipoproteins. 34 Protein concentrations were determined according to the method of Markwell et al 35 and phospholipids quantification was determined according to the method of Bartlett. 36 The total mass of lipoproteins was estimated by adding the mass of all components in each fraction.
Statistical Analysis
Statistical analysis was performed by using StatView II software. The differences between all transgenic rabbit groups and controls were evaluated by the 2-tailed Student's t test for unpaired data or by the Mann-Whitney U test for variables found not normally distributed when tested with the Kolgomorov-Smirnov test. Statistical significance between groups had a probability value of Ͻ0.05. Figure 1 shows the plasma lipids of nontransgenic and transgenic animals on the chow diet and after 10 weeks on the 0.3% cholesterol-enriched diet. In nontransgenic rabbits on chow, HDL cholesterol comprised Ϸ75% of circulating plasma cholesterol, whereas in both HL and apoE transgenic animals, there was a pronounced shift in lipoprotein cholesterol distribution with HDL cholesterol comprising Ϸ30% and 50% of the total. Combined expression of HL and apoE resulted in lower levels of HDL cholesterol and triglyceride than were found in the HL transgenic rabbits (Figure 1 ). In all experimental groups, the increased plasma cholesterol levels on the high-cholesterol diet were almost entirely (Ͼ95%) in the non-HDL fraction (Figure 1 ). Compared with nontransgenic controls, both the HL and the apoE transgenic rabbits had dramatically lower concentrations of total and HDL cholesterol; levels of triglyceride were also significantly lower in the HL rabbits. Rabbits overexpressing both apoE and HL had remarkably low concentrations of plasma lipids compared with the other experimental groups.
Results
Plasma Lipid and Lipoprotein Concentrations
Measurements of total mass concentrations of the major plasma lipoprotein fractions (Table) showed effects of the high-cholesterol diets consistent with those found for plasma cholesterol and triglyceride. On the high-cholesterol diet, compared with controls, levels of VLDLϩIDL were significantly lower in both HL and apoE transgenic rabbits and were further reduced in the combined transgenic animals. LDL mass concentrations were significantly lower in the HL transgenics than in the controls; mean values for the other 2 groups were similar, but the differences from the controls did not reach statistical significance. Differences in HDL mass concentrations among the groups paralleled those for HDL cholesterol (Figure 1 ), although levels in the combined transgenic animals, and in the HL animals on chow, were too low to permit measurement.
Lipoprotein Subfraction Analyses
Density and Size Distributions of VLDLs, IDLs, and LDLs
In subsets of each experimental group on the high-cholesterol diet, AnUC measurements were performed to evaluate the distribution of lipoprotein mass within the spectrum of VLDL, IDL, and LDL subfractions. In addition, nondenaturing GGE was performed on plasma and the VLDLϩIDL (dϽ1.019 g/mL) and LDL (dϭ1.019 to 1.063 g/mL) fractions from all animals to assess the diameter of the major species in each fraction. Mean AnUC profiles for each subgroup are shown in Figure 2 . The Sf°ranges designating VLDLs, IDLs, and LDLs are similar to those for humans, 30 except that rabbit VLDLs extend to a lower value (17 versus 20) , which corresponds to a buoyant density of 1.010 g/mL (Rizzo M, Barbagallo CM, and Krauss RM, unpublished observations). Several components were observed within the VLDL Sf°r ange in the nontransgenic rabbits. These were grouped into intervals designated large, medium, and small VLDLs. In addition, there was a peak of very large VLDLs extending to Sf°Ͼ400, a region that includes chylomicron-sized particles. 30 In the HL transgenic rabbits, AnUC revealed a predominance of large and very large VLDLs, with a marked depletion of medium and small VLDLs and IDLs in comparison with nontransgenic controls. The diameter of the major VLDL peak, as assessed by GGE, was not different between HL transgenic and control rabbits (ie, 448Ϯ4 versus 450Ϯ3 Å, respectively). There was, however, a shift to smaller, denser LDL particles (Sf°4 to 6, Figure 2 ) in the HL transgenic rabbits. Mean diameter of the major LDL GGE band (263Ϯ2 Å) was significantly smaller than that in controls (290Ϯ3 Å, PϽ0.001).
In sharp contrast to the results for the HL transgenic rabbits, the apoE transgenic animals exhibited near absence of large and medium VLDLs with a selective accumulation of small VLDLs and IDLs (Figure 2 ). This finding was corroborated by GGE (results not shown), which revealed a significantly smaller diameter of the major VLDL species in the HL rabbits (334Ϯ4 Å) than in the controls (PϽ0.0001). AnUC also indicated a shift toward LDLs of higher Sf°in apoE transgenic rabbits than controls (Figure 3 ), but mean peak LDL particle diameter as measured by GGE was not significantly larger than that in controls (298Ϯ3 versus 290Ϯ4 Å, respectively).
In the combined HLϩapoE transgenic rabbits, amounts of all VLDL species were much lower than in the other groups, with little detectable large and medium VLDLs of Sf°Ͼ80 and with reduced IDLs and LDLs compared with controls. Peak particle diameters of the VLDLϩIDL (320Ϯ4 Å) and LDL (272Ϯ3 Å) fractions were significantly smaller than those in controls (PϽ0.01 and 0.05, respectively). Figure 3 displays mean protein concentrations for dϽ1.019 g/mL lipoprotein subfractions separated by DGUC in all groups of animals. Also shown are mean particle diameters of the predominant peaks within these fractions, which permit their grouping into large, medium, and small VLDLs and IDLs. Consistent with the AnUC results, control rabbits had an accumulation of particles in all VLDL fractions, with lower levels of IDLs. In the HL transgenic rabbits, levels of all VLDL and IDL particles were reduced significantly compared with controls, with the exception of fraction 1, the largest fraction (diameter Ͼ400 Å), and of fraction 9, the smallest fraction. For rabbits overexpressing apoE, levels of the 3 fractions having the largest particle diameter were Table. significantly lower than controls. In rabbits expressing both HL and apoE, DGUC analyses again indicated very low concentrations of VLDL along the entire density and size spectrum. GGE analysis of individual DGUC fractions (data not shown) revealed that the higher density VLDL fractions contained both small VLDLs and abnormally large particles corresponding to the large VLDL peak (Sf°Ͼ400) observed in whole plasma (Figure 2 ). The failure to detect such particles as lipoproteins of Sf°Ͼ80 by analytic ultracentrifugation ( Figure 2 ) suggests abnormal physical properties of these larger sized particles. Mean concentrations of LDL-density subfractions are shown in Figure 4 . Control rabbits accumulated predominantly large LDLs, whereas HL rabbits had significantly lower mass levels of large LDLs in fractions 1 through 3 and significantly increased levels of smaller, denser LDLs in fractions 6 and 7 than nontransgenic animals. Rabbits overexpressing apoE showed significant reductions of mass of all LDL fractions except the largest and the combined HLϩapoE transgenic rabbits had significantly lower levels of the large LDL subclasses compared with controls.
DGUC of ApoB-Containing Lipoproteins
VLDLϩIDL
HDL Subfraction Analyses
Distributions of protein mass within HDL subspecies as assessed by GGE are shown in Figures 5 and 6 . In nontransgenic controls, particles corresponding to human HDL 2b and HDL 2a were most abundant with lesser amounts of larger sized particles, as well as a band corresponding in size to human HDL 3a . In HL transgenic rabbits, we found significantly reduced concentrations in all the major subclasses, with a marked narrowing of the particle size distributions corresponding to HDL 2b and HDL 2a . ApoE transgenic rabbits had a selective reduction in HDL 1 and HDL 2b , with nonsignificant changes in levels of smaller sized HDL particles and combined HLϩapoE transgenic rabbits showed a marked depletion of particles across the spectrum of subclasses. 
Discussion
The cholesterol-fed rabbit has been used for many years as an experimental model for the study of diet-induced hypercholesterolemia and atherosclerosis. 38 In previous studies in HL transgenic rabbits, we reported a marked reduction of IDLs and HDLs on a chow diet, as well as a reduced plasma cholesterol response to a high-cholesterol diet. 14, 15 Here, we have used these HL transgenic rabbits, as well as rabbits expressing high levels of human apoE, 16 to determine the influence of these proteins singly and in combination on the plasma lipid and lipoprotein profiles induced by high-cholesterol feeding. We found that increased expression of either gene resulted in a substantial attenuation of the plasma cholesterol response to the diet and that there was a further dramatic reduction in this response in the HLϩapoE double transgenic animals. This appeared to result from complementary and synergistic effects of HL and apoE on the metabolism of apoB-containing lipoproteins, as well as HDLs.
We demonstrated by three different methods (GGE, AnUC, and DGUC) that the diet-induced hypercholesterolemia in the nontransgenic rabbits was characterized by high levels of multiple distinct lipoprotein subpopulations: large, buoyant VLDLs; medium VLDLs; small, dense VLDLs; IDLs; and large, buoyant LDLs. Our results indicate that HL and apoE affect the metabolism of these subspecies differently. Increased expression of HL caused a reduction of all species except large VLDLs. In contrast, apoE transgenic rabbits had a marked reduction of these large VLDL particles, with selective accumulation of IDLs and large LDLs.
HL has both triglyceride hydrolase and phospholipase activities, allowing it to participate in the final steps of lipolysis initiated by lipoprotein lipase, mediating the conversion of IDLs to LDLs. 1,39 -41 In addition, it enhances cell association of triglyceride-rich lipoprotein remnants by initiating their binding to cell surface heparin sulfate proteoglycans. 9, 42 Our results showing significantly reduced levels of small VLDLs and IDLs in HL transgenic rabbits are consistent with these functions of HL and with earlier suggestions that endogenous HL deficiency in rabbits may contribute to their hyperlipidemic response to cholesterol feeding. 43, 44 The accumulation of very large lipoproteins in these animals suggests that HL does not interact significantly with these particles. It has been reported previously that chylomicrons are poor substrates for HL in comparison with smaller lipoproteins. 45 In our study, samples were collected after an overnight fast, making it unlikely that our results are caused by the presence of significant amounts of chylomicrons in the VLDL fraction. 46, 47 The reduced levels of IDLs, and a shift toward smaller, denser LDL particles in the HL transgenic animals, are consistent with evidence that HL is involved in the production of smaller LDLs from IDLs and large LDL precursors. 24 , 48 However, we found that plasma levels of LDLs were reduced in these animals. Therefore, either LDLs were cleared more rapidly or there was increased clearance of LDL precursors.
In humans, a strong relation has been shown between plasma triglyceride levels and LDL density, a phenomenon thought to reflect in part lipolysis of larger LDLs that have become enriched in triglyceride as a result of cholesteryl ester transfer protein activity. 49 In this regard, it is noteworthy that reduced LDL size and density occurred with HL overexpression despite reduced plasma levels of triglyceride. This suggests that hepatic lipase may not require cholesteryl ester transfer protein-mediated triglyceride enrichment of LDLs to generate smaller, denser LDL particles.
The reduction of HDLs in the HL transgenic rabbits occurred in all size fractions, but there was a marked narrowing of the particle distribution within HDL 2b and HDL 2a . Preliminary data on HDL composition showed a low cholesteryl ester content in HL transgenic rabbits (data not shown), and it is possible that this contributed to reduced polydispersity in the HDL 2b and HDL 2a particle distributions. The basis for this is not evident, although it has been reported that HL may promote selective hepatic removal of HDL cholesteryl esters as a result of its phospholipase activity. 50 It may also be that a subset of HDL 2 particles are resistant to HL.
In contrast with HL transgenic rabbits, lower levels of total VLDLϩIDL found in cholesterol-fed animals overexpressing apoE in this study were accounted for by a marked reduction in levels of large VLDL, presumably as a result of increased clearance. This mechanism is supported by the previous finding of an increased receptor affinity of VLDLs from apoE transgenic rabbits. 16 Previous studies have indicated that apoE is more effective in promoting the clearance of larger than smaller VLDL particles. [51] [52] [53] [54] [55] An enrichment of apoE on the lipoprotein surface relative to apoB or to apoCIII 56 or, alternatively, differences in steric accessibility or domain availability may mediate apoE function on distinct VLDL subclasses. It also has been reported that lipoprotein lipase-mediated hydrolysis of large VLDLs may be influenced by VLDL apoE content. 57 The increased removal of larger VLDLs in apoE transgenic rabbits may saturate or compete with mechanisms responsible for clearance of smaller remnant particles. 58 This may explain the accumulation of triglyceride-enriched particles in the IDL/large LDL particle spectrum in the apoE transgenic animals.
Analyses of HDLs in apoE transgenic rabbits revealed a selective reduction in larger particles, including those corresponding to human HDL 2b . It is known that apoE is preferentially transported on larger HDLs, including HDL 1 . 59 Therefore, it is possible that overexpression of apoE increases the amount of apoE on these particles, and thereby enhances their plasma clearance by receptor-dependent pathways.
The complementary functions of HL and apoE in lipoprotein metabolism were further demonstrated by simultaneous expression of both proteins in transgenic rabbits, which led to marked reductions of lipoproteins across the entire size and density spectrum. However, the extent of the reductions in plasma lipoprotein concentrations suggests that the interaction of HL and apoE is not merely additive, but synergistic. ApoE and HL may cooperate in the VLDL clearance process by facilitating the association of VLDLs with heparin sulfate proteoglycans on cell surfaces. In a similar manner, it has been reported that chylomicron remnants that are partially depleted of phospholipid and triglyceride content by HL treatment may have an accelerated clearance due to an enhanced exposure of apoE. 60 -62 In the case of HDLs, the synergistic effects of HL and apoE resulted in extremely low plasma levels of all the major HDL subspecies. The basis for this effect, and its potential impact on the development of atherosclerosis in this model, remains to be clarified.
